A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors
Clinical trial NCT07509684 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07509684
- Sponsor
- Zhejiang Anglikang Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-12-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.